Spain: Asabys Partners integrates with Aliath Bioventures life sciences investment platform in strategic move with...
Asabys Partners, a Spanish VC firm specialising in healthcare, and AltamarCAM Partners, a global investment firm specialised in private markets, have agreed to integrate Aliath Bioventures...
India: Somerset Indus Capital Partners exits Apex Hospitals as InvAscent invests
India-based life sciences-focused private equity firm InvAscent has invested INR2.3bn (US$24m) in Apex Hospitals, a critical care–focused multi-specialty hospital chain headquartered in Jaipur, Rajasthan.
“We...
Germany: Ottobock targets €4bn-plus market cap valuation from IPO
Shares in Germany-based prosthetics company Ottobock are to be offered in a tight €62.00 to €66.00 range in its upcoming IPO, valuing the company at...
The Netherlands: Genmab to acquire Merus in anticipation of potential billion-dollar petosemtamab revenues
Denmark-headquartered Genmab, a listed international biotechnology company, is acquiring Netherlands-based Merus, a listed clinical-stage biotechnology company, for US$97.00 per share in an all-cash transaction...
Spain: Fremman takes over reigns from Portobello to accelerate AGQ expansion
Fremman Capital, a pan-European, mid-market investment firm, has reached a definitive agreement to acquire a stake in AGQ Labs, a Spain-based global testing and...
Germany: Saesco Medical Group expands into Germany with acquisition of Firma Rivolution
Saesco Medical Group, a medical device distribution group based in Spain, has acquired Germany-based medical technology developer Firma Rivolution.
The acquisition will enhance Saesco's ability...
UK: Triton-backed Clinigen acquires SSI Strategy from Amulet Capital
UK-based Clinigen, a global, specialist pharmaceutical Services and Products company focused on providing ethical access to medicines, has agreed to acquire SSI Strategy, a...
Switzerland: Archimed accelerates expansion into biosimilars with acquisition of ExcellGene
Healthcare PE specialist Archimed has acquired a majority stake in Swiss-based, family-owned ExcellGene and sister company Magellan Biologics & Consulting (both in the biologic...
The Netherlands: Lupin strengthens ophthalmology business with acquisition of VISUfarma from GHO Capital
European specialist investor GHO Capital Partners has announced the sale of its portfolio company, VISUfarma, a pan-European specialty pharmaceutical company focused on ophthalmology, to...
Ireland: Erisberg completes €175m fundraise for second fund
Erisbeg, an Irish company that acquires and develops established businesses in Ireland and internationally, has confirmed the completion of its fundraise for the €175m...
















